Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 10;21(3):331.
doi: 10.3390/molecules21030331.

Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and Toxicology

Affiliations
Review

Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and Toxicology

Shaheed Ur Rehman et al. Molecules. .

Abstract

Eurycoma longifolia Jack (known as tongkat ali), a popular traditional herbal medicine, is a flowering plant of the family Simaroubaceae, native to Indonesia, Malaysia, Vietnam and also Cambodia, Myanmar, Laos and Thailand. E. longifolia, is one of the well-known folk medicines for aphrodisiac effects as well as intermittent fever (malaria) in Asia. Decoctions of E. longifolia leaves are used for washing itches, while its fruits are used in curing dysentery. Its bark is mostly used as a vermifuge, while the taproots are used to treat high blood pressure, and the root bark is used for the treatment of diarrhea and fever. Mostly, the roots extract of E. longifolia are used as folk medicine for sexual dysfunction, aging, malaria, cancer, diabetes, anxiety, aches, constipation, exercise recovery, fever, increased energy, increased strength, leukemia, osteoporosis, stress, syphilis and glandular swelling. The roots are also used as an aphrodisiac, antibiotic, appetite stimulant and health supplement. The plant is reported to be rich in various classes of bioactive compounds such as quassinoids, canthin-6-one alkaloids, β-carboline alkaloids, triterpene tirucallane type, squalene derivatives and biphenyl neolignan, eurycolactone, laurycolactone, and eurycomalactone, and bioactive steroids. Among these phytoconstituents, quassinoids account for a major portion of the E. longifolia root phytochemicals. An acute toxicity study has found that the oral Lethal Dose 50 (LD50) of the alcoholic extract of E. longifolia in mice is between 1500-2000 mg/kg, while the oral LD50 of the aqueous extract form is more than 3000 mg/kg. Liver and renal function tests showed no adverse changes at normal daily dose and chronic use of E. longifolia. Based on established literature on health benefits of E. longifolia, it is important to focus attention on its more active constituents and the constituents' identification, determination, further development and most importantly, the standardization. Besides the available data, more evidence is required regarding its therapeutic efficacy and safety, so it can be considered a rich herbal source of new drug candidates. It is very important to conserve this valuable medicinal plant for the health benefit of future generations.

Keywords: Eurycoma longifolia; pharmacological effects; quassinoids; safety; traditional herbal medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of various biological active constituents from E. longifolia; (A) 7-Methoxy-beta-carboline-1-propionic acid (C15); (B) 9-methoxycanthin-6-one (C15); (C) Laurycolactone (C17); (D) Eurycolactone B (C18); (E) Eurycomalide A (C19); (F) Eurylactone (C19); (G) Longilactone (C19); (H) Eurycomalactone (C19); (I) Eurycomanone (C20); (J) Eurycomanol (C20); (K) Pasakbumin B (C20); (L) Hydroxyklaineanone (C20); (M) Biphenyl-neolignan (C21); (N) Quassin (C22, basic ring of quassinoids); (O) Niloticin (C30); and (P) Eurylene (C34).

References

    1. Bodeker G., Ong C.K. WHO Global Atlas of Traditional, Complementary and Alternative Medicine. Volume 1 World Health Organization; Geneva, Switzerland: 2005.
    1. WHO . Traditional Medicine Strategy 2002–2005. World Health Organization; Geneva, Switzerland: 2002.
    1. Lancet J. Herbal remedies and the bias against Ayurveda. Curr. Sci. 2003;84:1165–1166.
    1. Duraz A.Y., Khan S.A. Knowledge, attitudes and awareness of community pharmacists towards the use of herbal medicines in muscat region. Oman Med. J. 2011;26 doi: 10.5001/omj.2011.115. - DOI - PMC - PubMed
    1. Patwardhan B., Vaidya A.D., Chorghade M. Ayurveda and natural products drug discovery. Curr. Sci. Bangalore. 2004;86:789–799.

Publication types